SCHEMBL29664342

SCHEMBL29664342

Nc1cccc(-c2cnn(-c3ccc(C(F)(F)F)cc3)c2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 1/20 0.57
FLT3 P36888 1/20 0.57
NPC1 O15118 3/20 0.52
RAB9A P51151 3/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 2/20 0.52
GRM4 Q14833 1/20 0.46
EPHX2 P34913 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
MAPT P10636 2/20 0.43
PKM P14618 1/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
PTGS2 P35354 1/20 0.42
HPGD P15428 2/20 0.40
MAP4K4 O95819 2/20 0.40
PSIP1 O75475 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23144557 1.00 NTRK1 (0.57) NTRK1FLT3NPC1RAB9AMEN1
SCHEMBL23144544 0.85 GRM4 (0.47) NTRK1FLT3NPC1RAB9AMEN1
SCHEMBL29664364 0.85 GRM4 (0.47) NTRK1FLT3NPC1RAB9AMEN1
SCHEMBL29664328 0.83 MKNK1 (0.50) NTRK1FLT3NPC1RAB9AMEN1
SCHEMBL23144521 0.83 MKNK1 (0.50) NTRK1FLT3NPC1RAB9AMEN1
SCHEMBL23144559 0.83 MAOA (0.55) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL29664332 0.83 MAOA (0.53) NPC1RAB9AMEN1KMT2AGRM4
SCHEMBL23144535 0.83 MAOA (0.53) NPC1RAB9AMEN1KMT2AGRM4
SCHEMBL23144576 0.82 MAP4K4 (0.44) NTRK1FLT3NPC1RAB9AMEN1
SCHEMBL29664194 0.82 MAP4K4 (0.44) NTRK1FLT3NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114728909-A Composition for preventing or treating cancer comprising novel trifluoromethylphenylpyrazole derivative as active ingredient 韩国原子力医学院 2022-07-08 CN disclosed